Dr. Pai’s is Professor and Chair of Clinical Pharmacy. He also is Co-Director of the Pharmacokinetics Core Laboratory and Associate Director of Pharmacomorphomics for the Morphomics Analysis Group at the University of Michigan. His research focus is optimal drug dose selection in specific populations such as obesity, lifespan, and healthspan. He earned his Pharm.D. from the University of Texas at Austin and Health Sciences Center in San Antonio, Texas. He completed a pharmacy practice residency at Bassett Healthcare in Cooperstown, New York, and an infectious diseases/pharmacokinetics fellowship at the University of Illinois at Chicago. Dr. Pai has close to 200 publications and has received multiple awards for his work.
- 2020 Excellence in Achievement, American College of Clinical Pharmacology
- 2019 Pharmacotherapy Paper of the Year, Society of Infectious Diseases Pharmacists
Pai MP. Antimicrobial Dosing in Specific Populations and Novel Clinical Methodologies: Kidney Function. Clin Pharmacol Ther. 2021 Apr;109(4):952-957.
Pai MP. Antimicrobial Dosing in Specific Populations and Novel Clinical Methodologies: Obesity.
Clin Pharmacol Ther. 2021 Apr;109(4):942-951.
Crass RL, Rodvold KA, Mueller BA, Pai MP. Renal Dosing of Antibiotics: Are We Jumping the Gun? Clin Infect Dis. 2018 Sep 13. doi: 10.1093/cid/ciy790.
Pai MP, Derstine B, Lichty M, Ross B, Sullivan J, Su G, Wang SL. Relationships of Vancomycin Pharmacokinetics to Body Size and Composition by Computed Tomography Analysis: A novel "Pharmacomorphomic" approach. Antimicrob Agents Chemother 2017 24;61(11). pii: e01402-17.
Pai MP. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults. Pharmacotherapy. 2012 Sep;32(9):856-68. Pai MP, Paloucek FP. The origin of the "ideal" body weight equations. Ann Pharmacother. 2000 Sep;34(9):1066-9.